Internal Medicine

Uzm. Dr. Ayla Avcu

Doctor and researcher Denizli Devlet Hastanesi Denizli
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInternal Medicinesaglik.gov.trFrom source
  • Department name at the sourceİç Hastalıkları (Dahiliye)saglik.gov.trFrom source
  • InstitutionDenizli Devlet Hastanesisaglik.gov.trFrom source
  • Publications10 publicationsORCID, OpenAlexFrom source
  • ORCID0000-0002-9043-3330ORCIDFrom source
  • Last synchronised5 November 2026 07:59https://denizlidh.saglik.gov.tr/TR-641584/doktorlarimiz.html#ayla-avcusaglik.gov.tr

Scientific work

Publications

10 publications

  1. Serum 14-3-3 eta levels in relation to attack status and amyloidosis in patients with Familial Mediterranean fever

    Biomarkers in Medicine, 2026

    DOI 10.1080/17520363.2026.2738633 PMID 42788745 Source: ORCID

  2. ABS0507 CORTICOSTEROID USE IN EARLY SYSTEMIC SCLEROSIS: INSIGHTS FROM THE TURKISH SYSTEMIC SCLEROSIS DATABASE

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1966 Open-access full textSource: OpenAlex

  3. ABS0480 DISTINGUISHING CLINICAL FEATURES BETWEEN LIMITED AND DIFFUSE SUBTYPES IN EARLY-STAGE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IS CHALLENGING

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1965 Open-access full textSource: OpenAlex

  4. ABS0575 EXPLORING THE ASSOCIATION BETWEEN AUTOANTIBODY PROFILES AND THE DEVELOPMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS PATIENTS: A COMPREHENSIVE ANALYSIS

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1975 Open-access full textSource: OpenAlex

  5. ABS0447 DOES OVERLAP SYNDROME CONTRIBUTE TO CLINICAL DIFFERENCES IN SYSTEMIC SCLEROSIS SKIN SUBTYPES

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1961 Open-access full textSource: OpenAlex

  6. ABS0539 TREATMENT PREFERENCES IN EARLY SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: REAL-WORLD DATA FROM THE TURKISH SYSTEMIC SCLEROSIS REGISTRY

    Annals of the Rheumatic Diseases, 2025

    DOI 10.1016/j.ard.2025.06.1969 Open-access full textSource: OpenAlex

  7. TRACING THE PATH TO DIAGNOSIS: INITIAL SYMPTOMS AND DELAYS IN SYSTEMIC SCLEROSIS FROM THETURKISH NATIONAL REGISTRY

    DSpace - FIRAT (Fırat University), 2025

    DOI 10.1136/annrheumdis-2025-eular.b2124 Open-access full textSource: OpenAlex

  8. AB1421 DETERMINATION OF THE RELATIONSHIP BETWEEN SERUM PROTEIN 14-3-3 ETA LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5812 Source: OpenAlex

  9. Serum triggering receptor expressed on myeloid cells-1 (TREM-1) levels may be associated with disease activity in patients with familial Mediterranean fever

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.79663 1 citation (OpenAlex) Open-access full textSource: ORCID

  10. Comment on: Efficacy of rituximab in slowing down progression of rheumatoid arthritis–related interstitial lung disease: data from the NEREA Registry

    Rheumatology, 2020

    DOI 10.1093/rheumatology/keaa171 PMID 32442283 2 citations (OpenAlex) Source: OpenAlex